UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE13a-16 OR15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2017
Commission File Number:001-31368
SANOFI
(Translation of registrant’s name into English)
54, rue La Boétie, 75008 Paris, FRANCE
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form20-F or Form40-F.
Form20-F ☒ Form40-F ☐
Indicate by check mark if the registrant is submitting the Form6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form6-K in paper as permitted by RegulationS-T Rule 101(b)(7): ☐
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule12g3-2(b) under the Securities Exchange Act of 1934.
Yes ☐ No ☒
If “Yes” marked, indicate below the file number assigned to the registrant in connection with Rule12g3-2(b):82-
In May Sanofi published information concerning First Quarter 2017 results, excerpted from information published on April 28, 2017 attached hereto as Exhibit 99.1 and which is incorporated herein by reference.
Exhibit List
Exhibit No. | Description | |
| Exhibit 99.1 | Information on Q1 2017 Financial Results | |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Dated: May 16, 2017 | SANOFI | |||||||
| By | /s/ Alexandra Roger | |||||||
| Name: | Alexandra Roger | |||||||
| Title: | Head of Securities Law and Capital Markets | |||||||
3
Exhibit Index
Exhibit No. | Description | |
| Exhibit 99.1 | Information on Q1 2017 Financial Results | |
4
